Invention Grant
US07276348B2 Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
有权
与F1F0-ATP酶抑制剂及其靶标有关的组合物和方法
- Patent Title: Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
- Patent Title (中): 与F1F0-ATP酶抑制剂及其靶标有关的组合物和方法
-
Application No.: US10795535Application Date: 2004-03-08
-
Publication No.: US07276348B2Publication Date: 2007-10-02
- Inventor: Gary D. Glick
- Applicant: Gary D. Glick
- Applicant Address: US MI Ann Arbor
- Assignee: Regents of the University of Michigan
- Current Assignee: Regents of the University of Michigan
- Current Assignee Address: US MI Ann Arbor
- Agency: Medlen & Carroll, LLP
- Main IPC: C12Q1/42
- IPC: C12Q1/42
Abstract:
The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and methods of using benzodiazepine derivatives as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, and hyperproliferation, and the like.
Public/Granted literature
- US20040241781A1 Compositions and methods relating to novel compounds and targets thereof Public/Granted day:2004-12-02
Information query
